share_log

CVS Health | 10-Q: Q1 2024 Earnings Report

CVS Health | 10-Q: Q1 2024 Earnings Report

西維斯健康 | 10-Q:2024財年一季報
美股SEC公告 ·  05/01 06:44
Moomoo AI 已提取核心訊息
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
CVS Health reported a decrease in operating income for the first quarter of 2024, with operating income falling to $2.271 billion from $3.446 billion in the same period last year. Adjusted operating income also declined to $2.957 billion from $4.370 billion year-over-year. The company's total revenues, however, saw a slight increase of 3.7%, reaching $88.437 billion, driven by growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments, despite a decline in the Health Services segment. Net income attributable to CVS Health saw a significant drop of 47.9%, from $2.136 billion to $1.113 billion. The Health Care Benefits segment experienced a 24.6% increase in total revenues, while the Health Services segment's revenues decreased by 9.7%. The Pharmacy & Consumer Wellness segment's revenues increased by 2.9%. CVS Health's future plans include growth in its new Cordavis, Oak Street Health, and Signify Health businesses, and the company expects to continue sharing a larger portion of rebates, fees, and discounts with clients. The company also anticipates ongoing enterprise-wide cost savings initiatives and investments in efficiencies to reduce operating costs sustainably.
西維斯健康報告2024年第一季度營業收入下降,營業收入從去年同期的34.46億美元下降到22.71億美元。調整後的營業收入也同比下降,從去年的43.7億美元降至29.57億美元。然而,公司的總收入實現了微小的增長,達到了884.37億美元,其中消費者健康保健和藥房及消費者健康部門的增長驅動了此增長,儘管醫療保健服務部門出現下滑。歸屬於西維斯健康的淨收入大幅下降47.9%,從21.36億美元降至11.13億美元。消費者健康保健部門總收入增長了24.6%,而醫療保健服務部門的收入下降了9.7%。藥房及消費者健康部門的收入增長了2.9%。西維斯健康的未來計劃包括擴大其新的 Cordavis、Oak Street Health 和 Signify Health 業務,並預計繼續與客戶分享更大部分的折扣、費用和回扣。該公司還預計實施企業範圍內的持續性降低運營成本的成本節約措施和投資效率。
西維斯健康報告2024年第一季度營業收入下降,營業收入從去年同期的34.46億美元下降到22.71億美元。調整後的營業收入也同比下降,從去年的43.7億美元降至29.57億美元。然而,公司的總收入實現了微小的增長,達到了884.37億美元,其中消費者健康保健和藥房及消費者健康部門的增長驅動了此增長,儘管醫療保健服務部門出現下滑。歸屬於西維斯健康的淨收入大幅下降47.9%,從21.36億美元降至11.13億美元。消費者健康保健部門總收入增長了24.6%,而醫療保健服務部門的收入下降了9.7%。藥房及消費者健康部門的收入增長了2.9%。西維斯健康的未來計劃包括擴大其新的 Cordavis、Oak Street Health 和 Signify Health 業務,並預計繼續與客戶分享更大部分的折扣、費用和回扣。該公司還預計實施企業範圍內的持續性降低運營成本的成本節約措施和投資效率。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息